One year after the first lockdown was announced in the UK we take a brief look at trends and changes...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreLast month, EMA published its overview of key recommendations for 2020 on the authorisation and safe...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreOur experts predict the 5 trends they think will dominate the European pricing and market access lan...
Read moreHTA bodies and companies within the pharmaceutical industry have been forced to react to unprecedent...
Read moreThe UK will continue to adopt decisions taken by the European Commission on the approval of new mark...
Read moreTo facilitate biosimilar uptake, several mechanisms encouraging biosimilar uptake have been implemen...
Read moreA survey of employees within pricing and market access n pharma and biotech companies.
Read more